Your browser doesn't support javascript.
loading
Chronic Hepatitis B Infection Among Preexposure Prophylaxis Users Enrolled in a Population-Based Program in British Columbia, Canada.
Thompson, Kyle A; Blank, Gabriel; Toy, Junine; Moore, David M; Lachowsky, Nathan; Bacani, Nicanor; Zhang, Wendy; Sereda, Paul; Lima, Viviane D; Barrios, Rolando; Montaner, Julio S G; Hull, Mark W.
Afiliação
  • Thompson KA; BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
  • Blank G; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Toy J; BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
  • Moore DM; BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
  • Lachowsky N; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Bacani N; School of Public Health and Social Policy, Faculty of Human and Social Development, University of Victoria, Victoria, British Columbia, Canada.
  • Zhang W; BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
  • Sereda P; BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
  • Lima VD; BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
  • Barrios R; BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
  • Montaner JSG; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Hull MW; BC Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Open Forum Infect Dis ; 8(11): ofab492, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34805433
ABSTRACT
Initiation of human immunodeficiency virus preexposure prophylaxis (PrEP) medications will also treat hepatitis B infection (HBV). The prevalence of chronic HBV was 0.86% (n=41/4760) among enrollees in a provincial PrEP program in British Columbia, Canada. Overall, 46.3% lacked follow-up HBV DNA monitoring, underscoring the need for HBV-related education for PrEP prescribers.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2021 Tipo de documento: Article